SSAO substrates exhibiting insulin-like effects in adipocytes as a promising treatment option for metabolic disorders.
作者:
主题词
3T3细胞(3T3 Cells);脂细胞(Adipocytes);脂肪因子类(Adipokines);胺氧化酶(含铜)(Amine Oxidase (Copper-Containing));动物(Animals);苄胺类(Benzylamines);基因表达调控(Gene Expression Regulation);葡萄糖(Glucose);人类(Humans);过氧化氢(Hydrogen Peroxide);胰岛素(Insulin);胰岛素抗药性(Insulin Resistance);胞间信号肽类和蛋白质类(Intercellular Signaling Peptides and Proteins);代谢疾病(Metabolic Diseases);小鼠(Mice);氨基脲类(Semicarbazides)
DOI
10.4155/fmc.10.260
PMID
21428797
发布时间
2022-03-21
- 浏览15

Future medicinal chemistry
1735-49页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文